Healthcare
Thursday, September 15, 2016
BRIEF-Rigel restructures to focus on Fostamatinib commercialization
* Rigel restructures to focus on fostamatinib
commercialization
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment